CTIX "Before the Bell" 1. The BIG question is when will we

New Post Public Reply Private Reply Replies (3) Message Board
BigJeff

CTIX "Before the Bell"

1. The BIG question is when will we hear about p21 expression, sooner or later? Good question . . . that is why we are still at $1.00 and that's why there is some "risk" associated with CTIX. (Sorry Kelt, I know you don't like the word "risk" but there is "risk" inherent in everything, like there was risk I might fall out of bed this morning. I know it is VERY small). You can be like most of us here and "load your boat" in confidence based on DD, past animal studies, interest in leading hospitals and big pharma to partner early in trials, and confidence in management, or you can sit on the sidelines and miss yet another opportunity of a lifetime. Your call!

2. Does anyone really believe that the love triangle with Gen. Patraeus actually compromised US intelligence? C'mon, how about spending one-tenth the time getting to the bottom of the Libya tragedy (big media) which actually saw the loss of lives.

3. I do believe we will go over the Fiscal Cliff . . . lots of consequences.

4. I'll bet that Andrew ARNP at Dana Farber is actually a nice guy. It's not his fault that Gov misinterprets and mis-communicates everything he says . . . that has been her routine with me and everyone else.

5. Is there any truth to the rumor that Gov, Eventheloser, and several other newbies on the iSnub board are leading an expedition to the Jamaican parish that Dr Menon served in to unearth the remains of the bull tested with Kevetrin?

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

BIC's Latest Voting Rights and Shares Disclosure Details

Updated Category News Views 180

Key Disclosure on Voting Rights and Shares As a reputable leader in stationery and consumer products, BIC is committed to transparency. Recently, they provided crucial insights into their corporate structure, particularly regarding the total number of voting rights and shares. This disclosure highlights the ongoing dedication towards maintaining clear communication with...

Continue Reading
AGCO Showcase: Innovations and Autonomy for 2026 Farmers

Updated Category News Views 212

AGCO (NYSE: AGCO) is strutting its stuff at the 2026 Commodity Classic in San Antonio from February 25-27. Picture this: over 24,000 square feet jam-packed with cutting-edge agricultural machinery aimed at farmers who want to boost their operations. Yeah, the buzz is all about showcasing their big guns like Fendt®, Massey Ferguson®, and PTx™—but dig deeper into...

Continue Reading
Revolutionizing Healthcare Marketing with Ignite Pulse Solutions

Updated Category News Views 371

Revolutionizing Healthcare Marketing with Ignite Pulse Solutions In the shifting landscape of healthcare marketing, WebMD Ignite introduces a significant enhancement aimed at assisting health systems in thriving amidst the challenges posed by AI and budget constraints. Presenting Ignite Pulse™, this groundbreaking solution offers a comprehensive growth strategy designed...

Continue Reading
Eupraxia Pharmaceuticals Welcomes New Leaders to Innovate Growth

Updated Category News Views 190

Eupraxia Pharmaceuticals Expands Leadership Team Eupraxia Pharmaceuticals Inc. (TSX: EPRX) (NASDAQ: EPRX), known for its innovative approaches in drug delivery technology, has recently announced two significant additions to its leadership. Dr. Amanda Malone has been appointed as the Chief Operating and Scientific Officer, alongside Dr. Rahul Sarugaser as Executive Vice...

Continue Reading
Illumina Enhances Oncology Solutions for Better Cancer Care

Updated Category News Views 186

Illumina's Latest Developments in Oncology In an exciting development, Illumina Inc. (NASDAQ: ILMN) has announced a significant expansion in its clinical oncology portfolio. This move aims to set a new standard of care and enhance access to precision therapies through advanced genomic profiling. Following the recent FDA approval of Illumina's TSO Comprehensive test, the...

Continue Reading